申请人:Imperial Chemical Industries Limited
公开号:US04338316A1
公开(公告)日:1982-07-06
The disclosure relates to 9.beta.-aryloxy prostane derivatives, for example 16-(3-chlorophenoxy)-11.alpha.,15.alpha.-dihydroxy-16-methyl-9.beta.-pheno xy-18,19,20-trinor-5-cis,13-trans-prostadienoic acid, which possess high activity as abortifacients, cervical softeners, inducers of parturition or inhibitors of gastric acid production in mammals. These properties are typical of prostaglandin analogues of the E series, but chemically the new 9.beta.-aryloxy prostane derivatives are prostaglandin F series analogues and are therefore more stable than the E series analogues previously used for the above purposes. The new derivatives are manufactured by known analogy processes, and are formulated in conventional manner.
本公开涉及9-beta-芳氧基前列腺素衍生物,例如16-(3-氯苯氧基)-11-alpha,15-alpha-二羟基-16-甲基-9-beta-苯氧基-18,19,20-三去-5-顺,13-反-前列环酸,具有在哺乳动物中作为流产药、宫颈软化剂、分娩诱导剂或胃酸抑制剂的高活性。这些性质是E系列前列腺素类似物的典型表现,但是新的9-beta-芳氧基前列酮衍生物在化学上是前列腺素F系列类似物,因此比以前用于上述目的的E系列类似物更稳定。新的衍生物通过已知的类比过程制造,并以传统方式制剂。